会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明申请
    • ABUNDANT EXTRACELLULAR PRODUCTS AND METHODS FOR THEIR PRODUCTION AND USE
    • 优质细胞产品及其生产和使用方法
    • WO1996037219A1
    • 1996-11-28
    • PCT/US1996007781
    • 1996-05-23
    • THE REGENTS OF THE UNIVERSITY OF CALIFORNIAHORWITZ, Marcus, A.HARTH, Günter
    • THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    • A61K39/04
    • C07K14/35A61K39/00A61K2039/51
    • Vaccines based on one or more combinations of majorly abundant extracellular products of pathogens and methods for their use and production are presented. The most prevalent or majorly abundant extracellular products of a target pathogen are selected irrespective of their absolute molecular immunogenicity and used as vaccines to stimulate a protective immune response in mammalian hosts against subsequent infection by the target pathogen. The majorly abundant extracellular products may be characterized and distinguished by their respective N-terminal amino acid, amino acid, or DNA sequences. As the vaccines may comprise different combinations of the extracellular products, subunits thereof, or encoding nucleic acids, a broad range of effective immunotherapeutic compositions are provided by the present invention. In addition to other infectious agents, the vaccines so produced can be used to stimulate an effective immune response against intracellular pathogens and in particular Mycobacterium tuberculosis.
    • 提出了基于病原体主要丰富细胞外产物的一种或多种组合的疫苗及其使用和生产方法。 选择目标病原体的最普遍或主要丰富的细胞外产物,而不管其绝对分子免疫原性如何,并且用作疫苗以在哺乳动物宿主中刺激保护性免疫应答,防止目标病原体随后感染。 主要丰富的细胞外产物可以通过它们各自的N-末端氨基酸,氨基酸或DNA序列来表征和区分。 由于疫苗可以包含细胞外产物,其亚基或编码核酸的不同组合,本发明提供了广泛的有效的免疫治疗组合物。 除了其它感染因子之外,如此产生的疫苗可用于刺激针对细胞内病原体,特别是结核分枝杆菌的有效免疫应答。
    • 3. 发明申请
    • METHOD OF ALLEVIATING NEUROPATHIC PAIN
    • 治疗神经痛疼痛的方法
    • WO1998039357A1
    • 1998-09-11
    • PCT/US1997016062
    • 1997-09-11
    • THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    • THE REGENTS OF THE UNIVERSITY OF CALIFORNIAO'BRIEN, John, S.
    • C07K04/00
    • C07K14/475A61K38/00
    • The invention provides a method of alleviating neuropathic pain in a subject by administering a neuropathic pain alleviating amount of prosaposin receptor agonist to the subject. The invention also provides a method of inhibiting the onset of neuropathic pain in a subject by administering neuropathic pain alleviating amount of prosaposin receptor agonist to the subject. The present invention also provides prosaposin receptor agonists and the use of these agonists for stimulating neurite outgrowth, inhibiting neural cell death, promoting myelination and inhibiting neural demyelination. In addition, there is provided a method of inhibiting sensory or motor neuropathy by contacting neuronal cells with a composition comprising an effective inhibiting amount of prosaposin receptor agonist.
    • 本发明提供了一种减轻受试者神经性疼痛的方法,该方法是通过对受试者施用神经性疼痛缓解量的prosaposin受体激动剂。 本发明还提供一种抑制受试者神经性疼痛发作的方法,该方法是向受试者施用神经性疼痛缓解量的prosaposin受体激动剂。 本发明还提供了prosaposin受体激动剂和这些激动剂用于刺激神经突生长,抑制神经细胞死亡,促进髓鞘形成和抑制神经脱髓鞘的用途。 此外,提供了通过使神经元细胞与包含有效抑制量的前列腺素受体激动剂的组合物接触来抑制感觉或运动神经病的方法。
    • 10. 发明申请
    • SOLUBLE PROTEINS
    • 可溶性蛋白质
    • WO1998020022A1
    • 1998-05-14
    • PCT/US1997006227
    • 1997-04-15
    • THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    • THE REGENTS OF THE UNIVERSITY OF CALIFORNIAPRUSINER, Stanley, B.COHEN, Fred, E.MURAMOTO, Tamaki
    • C07K01/00
    • C07K14/00A61K38/00C07K14/47C07K16/18
    • The invention includes deleting codon segments from DNA expressing a native protein in order to obtain a shorter, soluble protein which mimics characteristics of an insoluble native protein. Soluble proteins of the invention are characterized by: (1) having less amino acids than the full length native protein; (2) having a higher degree of solubility than the native protein; (3) retaining the basic biological characteristics of the native protein such as (a) not being subject to enzymatic digestion and (b) causing disease. Soluble proteins of the invention are obtained by providing a DNA sequence which encodes a native protein and systematically removing codons, making copies of the shortened versions of DNA which are then expressed to provide the shortened proteins. The shortened proteins are then tested for solubility. Soluble proteins are then further tested to confirm that they retain the biological characteristics of the native protein.
    • 本发明包括从表达天然蛋白质的DNA中删除密码子片段,以获得模拟不溶性天然蛋白质特征的较短的可溶性蛋白质。 本发明的可溶性蛋白质的特征在于:(1)具有比全长天然蛋白质少的氨基酸; (2)具有比天然蛋白质更高的溶解度; (3)保留天然蛋白质的基本生物学特性,如(a)不经酶消化和(b)引起疾病。 通过提供编码天然蛋白质的DNA序列并系统地除去密码子,制备DNA的缩短形式的拷贝,然后进行表达以提供缩短的蛋白质,从而获得本发明的可溶性蛋白质。 然后测试缩短的蛋白质的溶解度。 然后进一步测试可溶性蛋白质以证实它们保留天然蛋白质的生物学特性。